Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding [1] (multiple letters)

New England Journal of Medicine

Volumn 352, Issue 16, 2005, Pages 1716-1718

  Wolk, Michael J ^a   Jacobs, Alice K ^b   Wargo, Kurt A ^c   Baty, Sharon R ^d   Knowles, Gregg ^d   Barski Jr , Peter R ^e   Chan, Francis K L ^f  

^a AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^b AMERICAN HEART ASSOCIATION   (United States)

^c AUBURN UNIVERSITY   (United States)

^d HUNTSVILLE HOSPITAL   (United States)

^e Chinese University of Hong Kong ^*  (United States)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ESOMEPRAZOLE; ANTITHROMBOCYTIC AGENT; ANTIULCER AGENT; DRUG DERIVATIVE; PROTON PUMP; TICLOPIDINE;

CARDIOVASCULAR RISK; CLINICAL TRIAL; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERSENSITIVITY; LETTER; MEDICAL DECISION MAKING; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; RECURRENT DISEASE; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG COMBINATION; GASTROINTESTINAL HEMORRHAGE; NOTE; PRACTICE GUIDELINE; COST CONTROL; ECONOMICS; FEE; DRUG CONTRAINDICATION;

ANTI-ULCER AGENTS; ASPIRIN; CARDIOVASCULAR DISEASES; DRUG THERAPY, COMBINATION; GASTROINTESTINAL HEMORRHAGE; HUMANS; PEPTIC ULCER HEMORRHAGE; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES; PROTON PUMPS; RECURRENCE; TICLOPIDINE; COST SAVINGS; FEES, PHARMACEUTICAL;

EID: 17644414508     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200504213521617     Document Type: Letter

References (0)